Improving symptoms of pain, erectile dysfunction, and depression in patients on dialysis

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 1, 2013, Pages 5-7

  Hedayati, S Susan ^a,b  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO; SERTRALINE; SILDENAFIL;

DEPRESSION; DISEASE ASSOCIATION; EDITORIAL; ERECTILE DYSFUNCTION; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; OUTCOME ASSESSMENT; PAIN; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYMPTOM ASSESSMENT;

CHRONIC PAIN; DEPRESSIVE DISORDER; ERECTILE DYSFUNCTION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS;

EID: 84872199924     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11811112     Document Type: Editorial

References (20)

1. Weisbord SD, Carmody SS, Bruns FJ, Rotondi AJ, Cohen LM, Zeidel ML, Arnold RM: Symptom burden, quality of life, advance care planning and the potential value of palliative care in severely ill haemodialysis patients. Nephrol Dial Transplant 18: 1345-1352, 2003
2. Davison SN: Pain in hemodialysis patients: Prevalence, cause, severity, and management. Am J Kidney Dis 42: 1239-1247, 2003
3. Rosas SE, Joffe M, Franklin E, Strom BL, Kotzker W, Brensinger C, Grossman E, Glasser D, Feldman HI: Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int 59: 2259-2266, 2001
4. Hedayati SS, Yalamanchili V, Finkelstein FO: A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int 81: 247-255, 2012
5. Drayer RA, Piraino B, Reynolds CF 3rd, Houck PR, Mazumdar S, Bernardini J, Shear MK, Rollman BL: Characteristics of depression in hemodialysis patients: Symptoms, quality of life and mortality risk. Gen Hosp Psychiatry 28: 306-312, 2006
6. Soykan A, Boztas H, Kutlay S, Ince E, Aygor B, Ozden A, Nergizoglu G, Berksun O: Depression and its 6-month course in untreated hemodialysis patients: A preliminary prospective follow-up study in Turkey. Int J Behav Med 11: 243-246, 2004
7. Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, Veis JH: Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 57: 2093-2098, 2000
8. Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, Piera L, Held P, Gillespie B, Port FK; Dialysis Outcomes and Practice Patterns Study (DOPPS): Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 62: 199-207, 2002
9. Hedayati SS, Bosworth HB, Briley LP, Sloane RJ, Pieper CF, Kimmel PL, Szczech LA: Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int 74: 930-936, 2008
10. Weisbord SD, Fried LF, Mor MK, Resnick AL, Unruh ML, Palevsky PM, Levenson DJ, Cooksey SH, Fine MJ, Kimmel PL, Arnold RM: Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol 2: 960-967, 2007
11. Wuerth D, Finkelstein SH, Finkelstein FO: The identification and treatment of depression in patients maintained on dialysis. Semin Dial 18: 142-146, 2005
12. Blumenfield M, Levy NB, Spinowitz B, Charytan C, Beasley CM Jr, Dubey AK, Solomon RJ, Todd R, Goodman A, Bergstrom RF: Fluoxetine in depressed patients on dialysis. Int J Psychiatry Med 27: 71-80, 1997
13. Atalay H, Solak Y, Biyik M, Biyik Z, Yeksan M, Uguz F, Guney I, Tonbul HZ, Turk S: Sertraline treatment is associated with an improvement in depression and health-related quality of life in chronic peritoneal dialysis patients. Int Urol Nephrol 42: 527-536, 2010
14. Seibel I, Poli De Figueiredo CE, Teloken C, Moraes JF: Efficacy of oral sildenafil in hemodialysis patients with erectile dysfunction. J Am Soc Nephrol 13: 2770-2775, 2002
15. Barakzoy AS, Moss AH: Efficacy of the World Health Organization analgesic ladder to treat pain in end-stage renal disease. J Am Soc Nephrol 17: 3198-3203, 2006
16. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS; FHN Trial Group: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363: 2287-2300, 2010
17. Levendoglu F, Altintepe L, Okudan N, Ugurlu H, Gokbel H, Tonbul Z, Guney I, Turk S: A twelve week exercise program improves the psychological status, quality of life and work capacity in hemodialysis patients. J Nephrol 17: 826-832, 2004
18. Duarte PS, Miyazaki MC, Blay SL, Sesso R: Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney Int 76: 414-421, 2009
19. Weisbord SD, Mor MK, Green JA, Sevick MA, Shields AM, Zhao X, Rollman BL, Palevsky PM, Arnold RM, Fine MJ: Comparison of symptom management strategies for pain, erectile dysfunction, and depression in patients receiving chronic hemodialysis: A cluster randomized effectiveness trial. Clin J Am Soc Nephrol 8: 90-99, 2013
20. Weisbord SD, Shields AM, Mor MK, Sevick MA, Homer M, Peternel J, Porter P, Rollman BL, Palevsky PM, Arnold RM, Fine MJ: Methodology of a randomized clinical trial of symptom management strategies in patients receiving chronic hemodialysis: The SMILE study. Contemp Clin Trials 31: 491-497, 2010